Home / news / Hold Valeant Pharmaceuticals – Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Hold Valeant Pharmaceuticals – Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

collected by :Rechard Bernard

follow the latest news of” market news” from different sites to most famous technicals /Sa Editor Douglas W. House by 2017-01-11 at 0:43

as mentioned in

Valeant’s IDP-118 successful in second pivotal trial in plaque psoriasis; shares ahead 12% premarket – Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant's IDP-118 successful in second pivotal trial in plaque psoriasis; shares ahead 12% premarket - Valeant Pharmaceuticals International, Inc. (NYSE:VRX)*/

– Valeant Pharmaceuticals (NYSE:VRX) is up 12% premarket on increased volume in response to two asset sales but also stoked by positive results in a second Phase 3 study assessing IDP-118 (halobetasol propionate and tazarotene) lotion for the treatment of plaque psoriasis.The 203-subject study met its primary endpoint of a statistically significant percentage of participants with treatment success compared to vehicle.Treatment success was defined as the achievement of a “clear” to “almost clear” score and at least a two-grade improvement as measured by a scale called Investigator Global Assessment (IGA).
.

read more from here

Valeant And The Secret Recipe To Deleverage, Survive And Flourish – Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Valeant And The Secret Recipe To Deleverage, Survive And Flourish - Valeant Pharmaceuticals International, Inc. (NYSE:VRX)*/

– By Parke ShallValeant (NYSE:VRX) is trading higher this morning by double digits on much anticipated news that the company has finally sold some assets and begun what the market believes is an absolutely critical deleveraging process.This is a positive for VRX, not only because the company is doing the obvious and deleveraging to pay off some debt, but also because they got decent terms on the assets that they sold.Also, because it breaks a long period of time in which VRX was rumored to be making assets sales, but haven’t been able to get anything done.
.

read more from here

Hold Valeant Pharmaceuticals – Valeant Pharmaceuticals International, Inc. (NYSE:VRX)

Hold Valeant Pharmaceuticals - Valeant Pharmaceuticals International, Inc. (NYSE:VRX)*/

– Value investors face paper losses when picking a bottom for a stock.The more the stock falls, the more discounted the stock looks from its intrinsic value.Valeant Pharmaceuticals (NYSE:VRX) faced so many headwinds in 2016 that its only accomplishment on the market was not closing at a yearly low.
.

read more from here

Investor Notebook: Focusing in on Shares of Valeant Pharmaceuticals International Inc. (VRX.TO)

Investor Notebook: Focusing in on Shares of Valeant Pharmaceuticals International Inc. (VRX.TO)*/

– Equity traders may be partly leaning on technical stock analysis.Valeant Pharmaceuticals International Inc. (VRX.TO) presently has a 14-day Commodity Channel Index (CCI) of 81.62.The CCI was created to typically stay within the reading of -100 to +100.
.

read more from here

read more
visit us
news

About finance market

Avatar for finance market

Check Also

U.S. Government Spends Your Tax Dollar As tax day approaches picture-12359-310x165

U.S. Government Spends Your Tax Dollar As tax day approaches

The so-called Tax March falls on April 15, the nation’s traditional deadline for submitting tax …